DA-10770/DA/NIDA NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
1998	1
2000	2
2001	3
2003	2
2004	2
2007	1
2021	0

1

Mice with deficiency of G protein gamma3 are lean and have seizures.

Schwindinger WF, Giger KE, Betz KS, Stauffer AM, Sunderlin EM, Sim-Selley LJ, Selley DE, Bronson SK, Robishaw JD. Schwindinger WF, et al. Mol Cell Biol. 2004 Sep;24(17):7758-68. doi: 10.1128/MCB.24.17.7758-7768.2004. Mol Cell Biol. 2004. PMID: 15314181 Free PMC article.

2

Inhibitory effects of SR141716A on G-protein activation in rat brain.

Sim-Selley LJ, Brunk LK, Selley DE. Sim-Selley LJ, et al. Eur J Pharmacol. 2001 Mar 2;414(2-3):135-43. doi: 10.1016/s0014-2999(01)00784-1. Eur J Pharmacol. 2001. PMID: 11239913

3

Region-dependent attenuation of mu opioid receptor-mediated G-protein activation in mouse CNS as a function of morphine tolerance.

Sim-Selley LJ, Scoggins KL, Cassidy MP, Smith LA, Dewey WL, Smith FL, Selley DE. Sim-Selley LJ, et al. Br J Pharmacol. 2007 Aug;151(8):1324-33. doi: 10.1038/sj.bjp.0707328. Epub 2007 Jun 18. Br J Pharmacol. 2007. PMID: 17572699 Free PMC article.

4

Effect of strain and sex on mu opioid receptor-mediated G-protein activation in rat brain.

Selley DE, Herbert JT, Morgan D, Cook CD, Picker MJ, Sim-Selley LJ. Selley DE, et al. Brain Res Bull. 2003 May 15;60(3):201-8. doi: 10.1016/s0361-9230(03)00014-5. Brain Res Bull. 2003. PMID: 12754081

5

mu Opioid receptor-mediated G-protein activation by heroin metabolites: evidence for greater efficacy of 6-monoacetylmorphine compared with morphine.

Selley DE, Cao CC, Sexton T, Schwegel JA, Martin TJ, Childers SR. Selley DE, et al. Biochem Pharmacol. 2001 Aug 15;62(4):447-55. doi: 10.1016/s0006-2952(01)00689-x. Biochem Pharmacol. 2001. PMID: 11448454

6

Activation of G-proteins by morphine and codeine congeners: insights to the relevance of O- and N-demethylated metabolites at mu- and delta-opioid receptors.

Thompson CM, Wojno H, Greiner E, May EL, Rice KC, Selley DE. Thompson CM, et al. J Pharmacol Exp Ther. 2004 Feb;308(2):547-54. doi: 10.1124/jpet.103.058602. Epub 2003 Nov 4. J Pharmacol Exp Ther. 2004. PMID: 14600248

7

Region-specific changes in 5-HT(1A) receptor-activated G-proteins in rat brain following chronic buspirone.

Sim-Selley LJ, Vogt LJ, Xiao R, Childers SR, Selley DE. Sim-Selley LJ, et al. Eur J Pharmacol. 2000 Feb 18;389(2-3):147-53. doi: 10.1016/s0014-2999(99)00875-4. Eur J Pharmacol. 2000. PMID: 10688978

8

Agonist efficacy and receptor efficiency in heterozygous CB1 knockout mice: relationship of reduced CB1 receptor density to G-protein activation.

Selley DE, Rorrer WK, Breivogel CS, Zimmer AM, Zimmer A, Martin BR, Sim-Selley LJ. Selley DE, et al. J Neurochem. 2001 May;77(4):1048-57. doi: 10.1046/j.1471-4159.2001.00308.x. J Neurochem. 2001. PMID: 11359870 Free article.

9

Chronic heroin self-administration desensitizes mu opioid receptor-activated G-proteins in specific regions of rat brain.

Sim-Selley LJ, Selley DE, Vogt LJ, Childers SR, Martin TJ. Sim-Selley LJ, et al. J Neurosci. 2000 Jun 15;20(12):4555-62. doi: 10.1523/JNEUROSCI.20-12-04555.2000. J Neurosci. 2000. PMID: 10844025 Free PMC article.

10

Endomorphin-stimulated [35S]GTPgammaS binding in rat brain: evidence for partial agonist activity at mu-opioid receptors.

Sim LJ, Liu Q, Childers SR, Selley DE. Sim LJ, et al. J Neurochem. 1998 Apr;70(4):1567-76. doi: 10.1046/j.1471-4159.1998.70041567.x. J Neurochem. 1998. PMID: 9523574 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results